Prolonged infusion of beta-lactam antibiotics for Gram-negative infections: rationale and evidence base
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Infectious Diseases,Microbiology (medical)
Reference66 articles.
1. ‘Continuous’ vs. ‘discontinuous’ therapy with penicillin; the effect of the interval between injections on therapeutic efficacy;Eagle;N Engl J Med,1953
2. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men;Craig;Clin Infect Dis,1998
3. Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis;Abdul-Aziz;Intensive Care Med,2016
4. A multicenter randomized trial of continuous versus intermittent beta-lactam infusion in severe sepsis;Dulhunty;Am J Respir Crit Care Med,2015
5. Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial;Dulhunty;Clin Infect Dis,2013
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic Shock;JAMA;2024-08-27
2. Prolonged versus intermittent β-lactam infusion in sepsis: a systematic review and meta-analysis of randomized controlled trials;Annals of Intensive Care;2024-02-18
3. Prolonged vs intermittent intravenous infusion of β-lactam antibiotics for patients with sepsis: a systematic review of randomized clinical trials with meta-analysis and trial sequential analysis;Annals of Intensive Care;2023-12-05
4. Real-Life Experience of Continuously Infused Ceftolozane/Tazobactam in Patients with Bronchiectasis and Multidrug-Resistant Pseudomonas aeruginosa Infection in the Outpatient Setting;Antibiotics;2023-07-21
5. Extended and Continuous Infusion of Novel Protected β-Lactam Antibiotics: A Narrative Review;Drugs;2023-06-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3